首页> 外国专利> POLYMORPH OF (4-HYDROXYCARBAMOYLPHENYL)CARBAMINIC ACID (6-DIETHYLAMINOMETHYL-2-NAPHTHALENYL)METHYL ETHER HYDROCHLORIDE

POLYMORPH OF (4-HYDROXYCARBAMOYLPHENYL)CARBAMINIC ACID (6-DIETHYLAMINOMETHYL-2-NAPHTHALENYL)METHYL ETHER HYDROCHLORIDE

机译:(4-羟基氨基甲酰基)氨基甲酸(6-二乙氨基甲酰基-2-萘甲酰基)甲基氯醚的多态性

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention relates to a novel crystalline form of a compound of formula , which possesses higher solubility in water and storage stability. The novel crystalline form II of formula (A) compound is characterised by the presence of a profile of powder X-ray diffraction with the following peaks ±0.20° (2 theta): 5.10; 10.07; 14.90; 15.15; 15.67; 17.24; 17.84; 18.51; 19.23; 20.25; 20.37; 22.01; 22.63; 23.12; 24.76; 25.40; 27.78; 28.97; 31.02. The invention also relates to a method of obtaining the formula (A) compound in the crystalline form II and solid pharmaceutical compositions, containing the said crystalline form.;EFFECT: obtaining the novel n crystalline form of the compound.;11 cl, 2 tbl, 5 dwg, 5 ex
机译:技术领域:本发明涉及式(I)的化合物的新型晶形。<图像文件=“ 00000005.GIF” he =“ 44” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 84” />,在水中具有较高的溶解度和储存稳定性。式(A)化合物的新的晶型II的特征在于存在粉末X射线衍射的轮廓,其具有以下峰±0.20°(2θ):5.10;实测值:0.50。 10.07; 14.90; 15.15; 15.67; 17.24; 17.84; 18.51; 19.23; 20.25; 20.37; 22.01; 22.63; 23.12; 24.76; 25.40; 27.78; 28.97; 31.02。本发明还涉及获得结晶形式II的式(A)化合物的方法和包含所述结晶形式的固体药物组合物;效果:获得化合物的新型n结晶形式; 11 cl,2 tbl ,5 dwg,5 ex

著录项

  • 公开/公告号RU2552354C2

    专利类型

  • 公开/公告日2015-06-10

    原文格式PDF

  • 申请/专利权人 KEMI SPA;

    申请/专利号RU20120134703

  • 申请日2010-12-03

  • 分类号C07C271/28;C07C269/08;A61K31/27;

  • 国家 RU

  • 入库时间 2022-08-21 14:56:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号